Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities
Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in l...
Gespeichert in:
Veröffentlicht in: | Journal of vascular surgery 1997-10, Vol.26 (4), p.647-656 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 656 |
---|---|
container_issue | 4 |
container_start_page | 647 |
container_title | Journal of vascular surgery |
container_volume | 26 |
creator | Tassiopoulos, Apostolos K. Carlin, Robert E. Gao, Yuqi Pedoto, Alessia Finck, Christine M. Landas, Steve K. Tice, Diane G. Marx, William Hakim, Tawfic S. McGraw, Daniel J. |
description | Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R.
Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF
bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R
I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury.
Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF
bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF
bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF
bp had a protective effect on the lungs.
Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caus |
doi_str_mv | 10.1016/S0741-5214(97)70065-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79391583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074152149770065X</els_id><sourcerecordid>79391583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</originalsourceid><addsrcrecordid>eNqFkMlqHDEQQIVxsCdOPsGggzHJoWNpWsvoZILJBoZAFvBNqNUlW6ZbGmtJPH8fjWeYa05FUa-2h9A5JR8ooeLqJ5GMdnxJ2Tsl30tCBO_ujtCCEiU7sSLqGC0OyCl6nfMjIZTylTxBJ6rnkgm5QPVHnABHh4MvyVscn_0I2IQRlzrHhAPYFLPP2BlbWh4Dnmq4xz481rTB1tQMIx422Gf7ALM3VwnWkFzNvqFtbnkAPMW_kDA8l9SI4iG_Qa-cmTK83ccz9Pvzp183X7vb71--3Xy87SzrRenGfhiEWjlgjBkuGMgBqFOCCcslDHYQlhHJaU8Z74mjgwHLHTdSOsL4CP0ZutzNXaf4VCEXPbc7YZpMgFizlqpXzUjfQL4Dt9_mBE6vk59N2mhK9Fa3ftGtty61kvpFt75rfef7BXWYYTx07f22-sW-brI1k0smWJ8P2JJwtiS0Ydc7DJqMPx6SztZDsDD6BLboMfr_HPIP8uCeqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79391583</pqid></control><display><type>article</type><title>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tassiopoulos, Apostolos K. ; Carlin, Robert E. ; Gao, Yuqi ; Pedoto, Alessia ; Finck, Christine M. ; Landas, Steve K. ; Tice, Diane G. ; Marx, William ; Hakim, Tawfic S. ; McGraw, Daniel J.</creator><creatorcontrib>Tassiopoulos, Apostolos K. ; Carlin, Robert E. ; Gao, Yuqi ; Pedoto, Alessia ; Finck, Christine M. ; Landas, Steve K. ; Tice, Diane G. ; Marx, William ; Hakim, Tawfic S. ; McGraw, Daniel J. ; From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</creatorcontrib><description>Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R.
Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF
bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R
I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury.
Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF
bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF
bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF
bp had a protective effect on the lungs.
Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caused by lower extremity I/R. (J Vasc Surg 1997;26:647-56.)</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/S0741-5214(97)70065-X</identifier><identifier>PMID: 9357467</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Animals ; Aorta, Abdominal ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Constriction ; Dexamethasone - pharmacology ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Enzyme Inhibitors - pharmacology ; Guanidines - pharmacology ; Hindlimb - blood supply ; Lung - blood supply ; Lung - metabolism ; Lung - pathology ; Male ; Medical sciences ; Nitric Oxide - metabolism ; Nitric Oxide - physiology ; Nitric Oxide Synthase - antagonists & inhibitors ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury - metabolism ; Reperfusion Injury - pathology ; Reperfusion Injury - physiopathology ; Tumor Necrosis Factor-alpha - analysis ; Tumor Necrosis Factor-alpha - physiology</subject><ispartof>Journal of vascular surgery, 1997-10, Vol.26 (4), p.647-656</ispartof><rights>1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</citedby><cites>FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0741-5214(97)70065-X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2054201$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9357467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tassiopoulos, Apostolos K.</creatorcontrib><creatorcontrib>Carlin, Robert E.</creatorcontrib><creatorcontrib>Gao, Yuqi</creatorcontrib><creatorcontrib>Pedoto, Alessia</creatorcontrib><creatorcontrib>Finck, Christine M.</creatorcontrib><creatorcontrib>Landas, Steve K.</creatorcontrib><creatorcontrib>Tice, Diane G.</creatorcontrib><creatorcontrib>Marx, William</creatorcontrib><creatorcontrib>Hakim, Tawfic S.</creatorcontrib><creatorcontrib>McGraw, Daniel J.</creatorcontrib><creatorcontrib>From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</creatorcontrib><title>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R.
Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF
bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R
I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury.
Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF
bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF
bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF
bp had a protective effect on the lungs.
Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caused by lower extremity I/R. (J Vasc Surg 1997;26:647-56.)</description><subject>Animals</subject><subject>Aorta, Abdominal</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Constriction</subject><subject>Dexamethasone - pharmacology</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Guanidines - pharmacology</subject><subject>Hindlimb - blood supply</subject><subject>Lung - blood supply</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase - antagonists & inhibitors</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - pathology</subject><subject>Reperfusion Injury - physiopathology</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><subject>Tumor Necrosis Factor-alpha - physiology</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlqHDEQQIVxsCdOPsGggzHJoWNpWsvoZILJBoZAFvBNqNUlW6ZbGmtJPH8fjWeYa05FUa-2h9A5JR8ooeLqJ5GMdnxJ2Tsl30tCBO_ujtCCEiU7sSLqGC0OyCl6nfMjIZTylTxBJ6rnkgm5QPVHnABHh4MvyVscn_0I2IQRlzrHhAPYFLPP2BlbWh4Dnmq4xz481rTB1tQMIx422Gf7ALM3VwnWkFzNvqFtbnkAPMW_kDA8l9SI4iG_Qa-cmTK83ccz9Pvzp183X7vb71--3Xy87SzrRenGfhiEWjlgjBkuGMgBqFOCCcslDHYQlhHJaU8Z74mjgwHLHTdSOsL4CP0ZutzNXaf4VCEXPbc7YZpMgFizlqpXzUjfQL4Dt9_mBE6vk59N2mhK9Fa3ftGtty61kvpFt75rfef7BXWYYTx07f22-sW-brI1k0smWJ8P2JJwtiS0Ydc7DJqMPx6SztZDsDD6BLboMfr_HPIP8uCeqQ</recordid><startdate>19971001</startdate><enddate>19971001</enddate><creator>Tassiopoulos, Apostolos K.</creator><creator>Carlin, Robert E.</creator><creator>Gao, Yuqi</creator><creator>Pedoto, Alessia</creator><creator>Finck, Christine M.</creator><creator>Landas, Steve K.</creator><creator>Tice, Diane G.</creator><creator>Marx, William</creator><creator>Hakim, Tawfic S.</creator><creator>McGraw, Daniel J.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971001</creationdate><title>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</title><author>Tassiopoulos, Apostolos K. ; Carlin, Robert E. ; Gao, Yuqi ; Pedoto, Alessia ; Finck, Christine M. ; Landas, Steve K. ; Tice, Diane G. ; Marx, William ; Hakim, Tawfic S. ; McGraw, Daniel J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Aorta, Abdominal</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Constriction</topic><topic>Dexamethasone - pharmacology</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Guanidines - pharmacology</topic><topic>Hindlimb - blood supply</topic><topic>Lung - blood supply</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase - antagonists & inhibitors</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - pathology</topic><topic>Reperfusion Injury - physiopathology</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><topic>Tumor Necrosis Factor-alpha - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tassiopoulos, Apostolos K.</creatorcontrib><creatorcontrib>Carlin, Robert E.</creatorcontrib><creatorcontrib>Gao, Yuqi</creatorcontrib><creatorcontrib>Pedoto, Alessia</creatorcontrib><creatorcontrib>Finck, Christine M.</creatorcontrib><creatorcontrib>Landas, Steve K.</creatorcontrib><creatorcontrib>Tice, Diane G.</creatorcontrib><creatorcontrib>Marx, William</creatorcontrib><creatorcontrib>Hakim, Tawfic S.</creatorcontrib><creatorcontrib>McGraw, Daniel J.</creatorcontrib><creatorcontrib>From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tassiopoulos, Apostolos K.</au><au>Carlin, Robert E.</au><au>Gao, Yuqi</au><au>Pedoto, Alessia</au><au>Finck, Christine M.</au><au>Landas, Steve K.</au><au>Tice, Diane G.</au><au>Marx, William</au><au>Hakim, Tawfic S.</au><au>McGraw, Daniel J.</au><aucorp>From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>1997-10-01</date><risdate>1997</risdate><volume>26</volume><issue>4</issue><spage>647</spage><epage>656</epage><pages>647-656</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R.
Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF
bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R
I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury.
Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF
bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF
bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF
bp had a protective effect on the lungs.
Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caused by lower extremity I/R. (J Vasc Surg 1997;26:647-56.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>9357467</pmid><doi>10.1016/S0741-5214(97)70065-X</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5214 |
ispartof | Journal of vascular surgery, 1997-10, Vol.26 (4), p.647-656 |
issn | 0741-5214 1097-6809 |
language | eng |
recordid | cdi_proquest_miscellaneous_79391583 |
source | MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
subjects | Animals Aorta, Abdominal Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Constriction Dexamethasone - pharmacology Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Enzyme Inhibitors - pharmacology Guanidines - pharmacology Hindlimb - blood supply Lung - blood supply Lung - metabolism Lung - pathology Male Medical sciences Nitric Oxide - metabolism Nitric Oxide - physiology Nitric Oxide Synthase - antagonists & inhibitors Rats Rats, Sprague-Dawley Reperfusion Injury - metabolism Reperfusion Injury - pathology Reperfusion Injury - physiopathology Tumor Necrosis Factor-alpha - analysis Tumor Necrosis Factor-alpha - physiology |
title | Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T06%3A33%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20nitric%20oxide%20and%20tumor%20necrosis%20factor%20on%20lung%20injury%20caused%20by%20ischemia/reperfusion%20of%20the%20lower%20extremities&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Tassiopoulos,%20Apostolos%20K.&rft.aucorp=From%20the%20Department%20of%20Surgery%20and%20the%20Department%20of%20Pathology,%20State%20University%20of%20New%20York%20Health%20Science%20Center&rft.date=1997-10-01&rft.volume=26&rft.issue=4&rft.spage=647&rft.epage=656&rft.pages=647-656&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/S0741-5214(97)70065-X&rft_dat=%3Cproquest_cross%3E79391583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79391583&rft_id=info:pmid/9357467&rft_els_id=S074152149770065X&rfr_iscdi=true |